DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

H.C. Wainwright Maintains Buy on ADMA Biologics, Lowers Price Target to $12

H.C. Wainwright analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and lowers the price target from $14 to $12.

Benzinga · 03/16/2020 11:24

H.C. Wainwright analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and lowers the price target from $14 to $12.